Form 8-K AQUINOX PHARMACEUTICALS, For: Oct 07
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Aquinox Pharma (AQXP) Will Review Full LEADERSHIP Trial Data at R&D Day
October 7, 2015 9:20 AM EDTOn October 7, 2015, Aquinox Pharma (NASDAQ: AQXP) will host an R&D Day in New York City from 8:30 AM to 10:00 AM Eastern Time. The Company will be reviewing the full data from its recently completed LEADERSHIP trial and provide an update on the clinical... More
